Depression Genetics as a Window Into Physical and Mental Health.
Depression Genetics as a Window Into Physical and Mental Health.
复制标题
DOI:
10.1016/j.biopsych.2022.09.027
复制
发表时间:
2022-12-15
影响因子:
10.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Preventing depression and its concomitant health issues is critical to promote healthy aging and extend lifespan. It is well known that depression and poor health are intertwined (1), but why remains an area of active inquiry. The idea that depression may share underlying biology—including common genetic mechanisms—with other health conditions is appealing, as knowledge of such mechanisms could inform treatments to ameliorate both. To that end, we are learning year upon year more about the complex genetic architecture of major depression (2), which provides us in theory with increasingly powerful genome-wide tools to study the relationship between depression and health. Thus far such tools have offered a valuable but relatively focused view of depression’s shared genetic risk with specific comorbidities, such as cardiovascular disease. On the other hand, the genetics underlying depression are expected to be highly pleiotropic (ie, associated with many traits) and could thus provide a window into a much broader spectrum of mental and physical illnesses—though this remains to be fully characterized. In this issue, Fang and colleagues (3) report results from one of the largest and most well-powered examinations to date of how genetic liability for depression relates to a wide range of physical and mental health conditions, conducting a phenome-wide association study (PheWAS) in real-world electronic health records (EHRs) from the Michigan Genomics Initiative, a hospital-embedded biobank with over 46,000 unrelated participants of European ancestry. Unlike the genome-wide association study (GWAS), which tests the associations between millions of common genetic variants and a single phenotype of interest, a PheWAS takes the reverse approach, where a single exposure of interest is assessed for its relationship to many phenotypes (4). While initial PheWAS efforts focused on specific genetic variants as an exposure (4), a PheWAS using polygenic scores—which aggregate the risk effects of many variants across the genome—is poised to take GWAS insights about complex psychiatric disorders back into the clinical research setting (Figure 1). Given their use in routine patient care, hospital EHRs naturally capture a broad range of clinical phenotypes for assessing pleiotropy and shared risk, which can be otherwise challenging to assemble.[FIGURE 1]
登录
查看更多内容
DOI:
10.1146/annurev-genom-090314-024956
发表时间:
2016-08-31
影响因子:
8.7
作者:
Denny JC;Bastarache L;Roden DM
通讯作者:
Roden DM
影响因子:
11
作者:
Dennis, Jessica;Sealock, Julia;Davis, Lea K.
通讯作者:
Davis, Lea K.
影响因子:
30.8
作者:
Werme, Josefin;van der Sluis, Sophie;de Leeuw, Christiaan A.
通讯作者:
de Leeuw, Christiaan A.
影响因子:
6.8
作者:
McCoy TH;Castro VM;Snapper L;Hart K;Januzzi JL;Huffman JC;Perlis RH
通讯作者:
Perlis RH
影响因子:
10.6
作者:
Fang, Yu;Fritsche, Lars G.;Richmond-Rakerd, Leah S.
通讯作者:
Richmond-Rakerd, Leah S.